Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ataluren in nonsense mutation cystic fibrosis (ACT CF)
NCT02139306Phase 3Completed
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Aug 2014
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of ataluren in cystic fibrosis (CF), sponsored by PTC Therapeutics, Inc.. Started Aug 2014; status: completed.
02
Drugs
ataluren
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT02139306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02139306.